May 2, 2023 — Ambiq, a leading developer of ultra-low-power semiconductor solutions that deliver a multifold increase in energy efficiency, introduces Ambiq HeartKit, its latest addition to neuralSPOT’s Model Zoo. This highly optimized AI model enables running various real-time heart monitoring applications to help users and their healthcare providers quickly identify any irregular events to take necessary actions.

May 2, 2023 — Auburn Community Hospital (ACH) announced today that Dr. Ronald L. Kirshner has been appointed Chair and Medical Director of the new Auburn Heart Institute (AHI). Dr.

May 2, 2023 — The Heart Rhythm Society (HRS) is making final preparations for its Annual Heart Rhythm Meeting, HRS2023, which continues to bring together the largest gathering of heart rhythm professionals from around the world. Attendees will join colleagues in person at the Ernest N.

VR technology provides surgical teams with additional insight and provides a more effective game plan.

Magnetic resonance imaging (MRI) is a technology that has been around for more than four decades and is a staple in healthcare. Like other long-established technologies, there have been ongoing improvements to MRI scans.

May 1, 2023 — Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. 

May 1, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that the first carotid artery disease patient has been treated utilizing CGuard Prime,

Top 10 articles viewed in April 2023 on dicardiology.com

As we head into Spring, let's take a look at the Top 10 topics that viewers were reading about during the month of April.

1. Atrial Fibrillation Market Reaches $20.92B, According to New Report

2. BLOG: Making a Case for the Variable Rate Contrast Injector

April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) also have left heart disease.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now